The Washington State Health Care Authority Health Technology Clinical Committee (HTCC) reviewed balloon angioplasty and stenting for lower extremity peripheral artery disease evidence Nov. 21. ACR® participated in the discussion along with the Society of Interventional Radiology, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, and the Outpatient Endovascular and Interventional Society. ACR began monitoring this topic in August 2025.
HTCC issued draft findings and a coverage decision that are open for public comment until Dec. 16. The coverage determination is for Endovascular therapy for activity-limiting intermittent claudication and chronic limb-threatening ischemia as a covered benefit with conditions. ACR members who perform these procedures are encouraged to submit feedback. Email comments to shtap@hca.wa.gov.
Final findings and coverage decisions will be published in March. Meeting materials and presentations are on the HTCC website.
For more information or if you have questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
ACR Joins Letter Urging $51.3 Billion for NIH in FY27
ACR urged Congress to provide at least $51.3 billion in funding for NIH in federal fiscal year 2027.
Read moreACR Achieves MUE Increase for 3D-Printed Add-on Codes
CMS raised MUEs for 3Dâprinted model and guide codes after ACRâs appeal, aligning units with clinical needs for complex surgical planning.
Read moreACR Partners with Fight CRC for United in Blue
ACR joins Fight CRCâs 2026 United in Blue on the National Mall, supporting awareness, early detection, and colorectal cancer advocacy.
Read more
